HealthCor Management as of March 31, 2022
Portfolio Holdings for HealthCor Management
HealthCor Management holds 64 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 5.6 | $85M | 402k | 210.60 | |
| Boston Scientific Corporation (BSX) | 5.5 | $82M | 1.9M | 44.29 | |
| Horizon Therapeutics Pub L SHS | 5.0 | $75M | 710k | 105.21 | |
| BioMarin Pharmaceutical (BMRN) | 4.0 | $59M | 769k | 77.10 | |
| Natera (NTRA) | 3.9 | $59M | 1.4M | 40.68 | |
| Abbott Laboratories (ABT) | 3.8 | $57M | 485k | 118.36 | |
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 3.6 | $54M | 600k | 89.88 | |
| Centene Corporation (CNC) | 3.6 | $53M | 635k | 84.19 | |
| AmerisourceBergen (COR) | 3.4 | $51M | 331k | 154.71 | |
| Humana (HUM) | 3.2 | $48M | 109k | 435.17 | |
| Cooper Cos Com New | 3.0 | $45M | 109k | 417.59 | |
| Envista Hldgs Corp (NVST) | 3.0 | $45M | 915k | 48.71 | |
| Cytokinetics Com New (CYTK) | 2.8 | $42M | 1.1M | 36.81 | |
| Abbvie (ABBV) | 2.7 | $41M | 254k | 162.11 | |
| Livanova SHS (LIVN) | 2.7 | $41M | 502k | 81.83 | |
| Incyte Corporation (INCY) | 2.7 | $40M | 500k | 79.42 | |
| Bristol Myers Squibb (BMY) | 2.6 | $39M | 530k | 73.03 | |
| Becton, Dickinson and (BDX) | 2.5 | $38M | 142k | 266.00 | |
| UnitedHealth (UNH) | 2.5 | $37M | 73k | 509.98 | |
| Anthem (ELV) | 2.4 | $36M | 73k | 491.22 | |
| Teleflex Incorporated (TFX) | 2.3 | $35M | 99k | 354.83 | |
| Universal Hlth Svcs CL B (UHS) | 2.2 | $33M | 228k | 144.95 | |
| McKesson Corporation (MCK) | 2.0 | $29M | 96k | 306.13 | |
| CVS Caremark Corporation (CVS) | 1.9 | $29M | 287k | 101.21 | |
| Danaher Corporation (DHR) | 1.9 | $29M | 98k | 293.33 | |
| Revance Therapeutics | 1.9 | $28M | 1.4M | 19.50 | |
| Amgen (AMGN) | 1.8 | $26M | 109k | 241.82 | |
| Tenet Healthcare Corp Com New (THC) | 1.6 | $24M | 284k | 85.96 | |
| Chemocentryx | 1.6 | $24M | 957k | 25.07 | |
| Pet Acquisition LLC -Class A (WOOF) | 1.6 | $24M | 1.2M | 19.57 | |
| Henry Schein (HSIC) | 1.5 | $22M | 255k | 87.19 | |
| Syndax Pharmaceuticals (SNDX) | 1.4 | $21M | 1.2M | 17.38 | |
| Cardinal Health (CAH) | 1.2 | $18M | 317k | 56.70 | |
| Research Alliance Corp Ii Com Cl A | 0.9 | $13M | 1.3M | 9.76 | |
| Pfizer (PFE) | 0.8 | $13M | 243k | 51.77 | |
| Hca Holdings (HCA) | 0.8 | $12M | 49k | 250.62 | |
| Stryker Corporation (SYK) | 0.8 | $12M | 44k | 267.34 | |
| Affimed Therapeutics B V | 0.5 | $7.5M | 1.7M | 4.37 | |
| Quanterix Ord (QTRX) | 0.5 | $7.2M | 247k | 29.19 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.5 | $7.1M | 200k | 35.27 | |
| Regeneron Pharmaceuticals (REGN) | 0.4 | $6.7M | 9.6k | 698.43 | |
| ImmunoGen | 0.4 | $6.2M | 1.3M | 4.76 | |
| Hyperfine Com Cl A (HYPR) | 0.4 | $6.2M | 1.8M | 3.54 | |
| Rapt Therapeutics | 0.4 | $5.8M | 264k | 21.99 | |
| Cano Health Com Cl A | 0.3 | $4.5M | 712k | 6.35 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $3.7M | 229k | 16.26 | |
| Alkermes SHS (ALKS) | 0.2 | $3.7M | 141k | 26.31 | |
| Ishares Tr Ishares Biotech (IBB) | 0.2 | $3.7M | 28k | 130.30 | |
| Stereotaxis Com New (STXS) | 0.2 | $3.1M | 822k | 3.73 | |
| Merus N V (MRUS) | 0.2 | $3.0M | 112k | 26.44 | |
| Neurocrine Biosciences (NBIX) | 0.1 | $2.2M | 24k | 93.74 | |
| Leap Therapeutics | 0.1 | $1.9M | 1.1M | 1.75 | |
| Ikena Oncology (IKNA) | 0.1 | $1.8M | 288k | 6.10 | |
| Galapagos Nv Spon Adr (GLPG) | 0.1 | $1.5M | 24k | 62.01 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.1 | $1.4M | 9.2k | 155.62 | |
| Geron Corporation (GERN) | 0.1 | $1.2M | 900k | 1.36 | |
| Pacira Pharmaceuticals (PCRX) | 0.1 | $1.1M | 14k | 76.31 | |
| Pyxis Oncology Common Stock (PYXS) | 0.1 | $879k | 218k | 4.04 | |
| Intra Cellular Therapies (ITCI) | 0.1 | $830k | 14k | 61.16 | |
| Longview Acquisition Corp Ii *w Exp 99/99/999 | 0.0 | $179k | 427k | 0.42 | |
| Eqrx *w Exp 12/17/202 | 0.0 | $81k | 100k | 0.81 | |
| Orion Acquisition Corp *w Exp 02/19/202 | 0.0 | $43k | 137k | 0.31 | |
| Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $35k | 83k | 0.42 | |
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $15k | 78k | 0.19 |